Cargando…

Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs

Cirrhosis is a form of liver fibrosis resulting from chronic hepatitis and caused by various liver diseases, including viral hepatitis, alcoholic liver damage, nonalcoholic steatohepatitis, and autoimmune liver disease. Cirrhosis leads to various complications, resulting in poor prognoses; therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishikawa, Koji, Osawa, Yosuke, Kimura, Kiminori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213128/ https://www.ncbi.nlm.nih.gov/pubmed/30308992 http://dx.doi.org/10.3390/ijms19103103

Ejemplares similares

Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
por: Kimura, Masamichi, et al.
Publicado: (2022)

Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
por: Tokunaga, Yuko, et al.
Publicado: (2017)

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers
por: Osawa, Yosuke, et al.
Publicado: (2019)

BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway
por: Zhangdi, Hanjing, et al.
Publicado: (2023)

Wnt/β-Catenin Signaling in Liver Cancers
por: Wang, Wenhui, et al.
Publicado: (2019)

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
por: Kimura, Kiminori, et al.
Publicado: (2017)

NOTCH1 activates the Wnt/β-catenin signaling pathway in colon cancer
por: Ishiguro, Hideyuki, et al.
Publicado: (2017)

Targeting the Wnt/β-catenin signaling pathway in cancer
por: Zhang, Ya, et al.
Publicado: (2020)

Wnt/β-catenin signaling in cancers and targeted therapies
por: Yu, Fanyuan, et al.
Publicado: (2021)

Tumor necrosis factor‐α‐mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice
por: Osawa, Yosuke, et al.
Publicado: (2018)

Wnt/β-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer
por: Zhu, Gui-Xian, et al.
Publicado: (2021)

WNKs in Wnt/β-catenin signaling
por: Serysheva, Ekatherina, et al.
Publicado: (2014)

Wnt/β-Catenin Signaling and Obesity
por: Chen, Na, et al.
Publicado: (2018)

Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers
por: Lecarpentier, Yves, et al.
Publicado: (2019)

Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer
por: Patergnani, Simone, et al.
Publicado: (2022)

Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
por: Jung, Youn-Sang, et al.
Publicado: (2020)

Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice
por: Osawa, Yosuke, et al.
Publicado: (2015)

Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma
por: Zhang, Guo-Feng, et al.
Publicado: (2020)

Canonical Wnt Signaling (Wnt/β-Catenin Pathway): A Potential Target for Cancer Prevention and Therapy
por: Najafi, S Mahmoud A
Publicado: (2020)

Rad6B acts downstream of Wnt signaling to stabilize β-catenin: Implications for a novel Wnt/β-catenin target
por: Gerard, Brigitte, et al.
Publicado: (2011)

Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
por: Lin, Chung-Ming, et al.
Publicado: (2017)

Understanding and Targeting the Wnt/β-Catenin Signaling Pathway in Chronic Leukemia
por: Thanendrarajan, S., et al.
Publicado: (2011)

Wnt/β-Catenin Signaling as a Molecular Target by Pathogenic Bacteria
por: Silva-García, Octavio, et al.
Publicado: (2019)

Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma
por: Sha, Ying-Li, et al.
Publicado: (2019)

Wnt/β-catenin signaling in heart regeneration
por: Ozhan, Gunes, et al.
Publicado: (2015)

Wnt/β-catenin signaling and kidney fibrosis
por: Tan, Roderick J, et al.
Publicado: (2014)

Regulation of Wnt/β-catenin signaling by herpesviruses
por: Zwezdaryk, Kevin J, et al.
Publicado: (2016)

Wnt/β-Catenin Signaling in Oral Carcinogenesis
por: Reyes, Montserrat, et al.
Publicado: (2020)

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study
por: Kimura, Kiminori, et al.
Publicado: (2022)

Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents
por: Selvaggi, Federico, et al.
Publicado: (2022)

Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide
por: Fako, Valerie, et al.
Publicado: (2016)

Wnt2 complements Wnt/β-catenin signaling in colorectal cancer
por: Jung, Youn-Sang, et al.
Publicado: (2015)

Surrogate Wnt agonists that phenocopy canonical Wnt/β-catenin signaling
por: Janda, Claudia Y., et al.
Publicado: (2017)

Precision-Cut Liver Slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis
por: Wang, Yongtao, et al.
Publicado: (2023)

Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling
por: Herbst, Andreas, et al.
Publicado: (2014)

Novel β-carbolines inhibit Wnt/β-catenin signaling
por: Kong, L, et al.
Publicado: (2015)

Therapeutic strategies targeting Wnt/β-catenin signaling for colorectal cancer (Review)
por: Ji, Yong, et al.
Publicado: (2022)

How does microRNA modulate Wnt/β-catenin signaling in thyroid oncogenesis?
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2020)

Pigment Epithelium-Derived Factor (PEDF) Inhibits Wnt/β-catenin Signaling in the Liver
por: Protiva, Petr, et al.
Publicado: (2015)

Cepharanthine hydrochloride inhibits the Wnt/β-catenin/Hedgehog signaling axis in liver cancer
por: Su, Gui-Feng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ads7e6libll4u61f65g4dupt2s